Angela Vincent Selected Research

Myoclonus (Nocturnal Myoclonus)

11/2019	Glycine receptor autoantibodies disrupt inhibitory neurotransmission.
1/2017	Redefining progressive encephalomyelitis with rigidity and myoclonus after the discovery of antibodies to glycine receptors.
8/2014	Glycine receptor antibodies in a boy with focal epilepsy and episodic behavioral disorder.
5/2014	Hypoventilation in glycine-receptor antibody related progressive encephalomyelitis, rigidity and myoclonus.
1/2014	Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes.
4/2013	Progressive encephalomyelitis with rigidity and myoclonus: the first pediatric case with glycine receptor antibodies.
1/2013	A pilot study on neurological manifestations and antibodies against antigens in children with hematological and other cancers.
12/2012	Supranuclear gaze palsy in glycine receptor antibody-positive progressive encephalomyelitis with rigidity and myoclonus.
8/2012	Glycine receptor antibodies are detected in progressive encephalomyelitis with rigidity and myoclonus (PERM) but not in saccadic oscillations.
12/2011	Antiglycine-receptor encephalomyelitis with rigidity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Angela Vincent Research Topics

Disease

86	Myasthenia Gravis 01/2022 - 01/2002
47	Encephalitis (Encephalitis, Rasmussen) 01/2022 - 10/2006
40	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 01/2018 - 06/2003
37	Seizures (Absence Seizure) 01/2021 - 09/2005
35	Neuromyelitis Optica (Devic's Disease) 12/2021 - 04/2007
30	Brain Diseases (Brain Disorder) 11/2018 - 03/2004
28	Epilepsy (Aura) 01/2019 - 06/2003
26	Glioma (Gliomas) 01/2020 - 09/2010
18	Isaacs Syndrome (Neuromyotonia) 01/2020 - 08/2002
17	Autoimmune Diseases (Autoimmune Disease) 12/2020 - 08/2002
16	Neoplasms (Cancer) 01/2016 - 08/2003
15	Psychotic Disorders (Schizoaffective Disorder) 12/2021 - 06/2011
14	Thymoma (Thymic Carcinoma) 11/2020 - 03/2003
13	Autoimmune Diseases of the Nervous System 01/2021 - 02/2014
13	Lambert-Eaton Myasthenic Syndrome (Lambert-Eaton Syndrome) 01/2020 - 03/2003
13	Multiple Sclerosis 05/2017 - 07/2003
12	Stiff-Person Syndrome (Stiff Man Syndrome) 11/2019 - 06/2003
11	Central Nervous System Diseases (CNS Diseases) 01/2022 - 05/2003
11	Inflammation (Inflammations) 01/2021 - 12/2007
11	Demyelinating Diseases (Demyelinating Disease) 07/2017 - 02/2010
10	Movement Disorders (Movement Disorder) 09/2020 - 10/2010
10	Myoclonus (Nocturnal Myoclonus) 11/2019 - 12/2011
9	Cognitive Dysfunction 01/2021 - 05/2011
8	Nervous System Diseases (Neurological Disorders) 10/2020 - 09/2008
8	Pain (Aches) 01/2020 - 05/2011
8	Progressive Encephalomyelitis with Rigidity 11/2019 - 12/2011
7	Arthrogryposis 01/2021 - 10/2002
7	Muscle Weakness 01/2020 - 02/2003
7	Atrophy 05/2017 - 06/2002
7	Complex Regional Pain Syndromes 01/2016 - 03/2005
6	Infections 01/2021 - 05/2011
6	Guillain-Barre Syndrome 10/2020 - 06/2009
6	Inborn Genetic Diseases (Disease, Hereditary) 01/2019 - 01/2002
6	Status Epilepticus (Complex Partial Status Epilepticus) 03/2016 - 11/2011
6	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2015 - 03/2003
5	Neurodevelopmental Disorders 08/2020 - 09/2002
5	Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis) 01/2016 - 04/2013
5	Transverse Myelitis (Necrotizing Myelitis) 04/2014 - 04/2007
4	Schizophrenia (Dementia Praecox) 01/2021 - 03/2005
4	Narcolepsy 09/2020 - 11/2013
4	Headache (Headaches) 01/2020 - 10/2011
4	Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital) 10/2019 - 06/2002
4	Disease Progression 01/2019 - 08/2012
4	Dyskinesias (Dyskinesia) 01/2018 - 01/2012
4	Rhabdomyosarcoma 10/2017 - 01/2006
4	Partial Epilepsies (Epilepsy, Partial) 08/2014 - 06/2013
4	Leukocytosis (Pleocytosis) 05/2014 - 04/2009
4	Spasm (Spasms) 05/2014 - 10/2011
3	Autism Spectrum Disorder 08/2020 - 01/2017
3	Autistic Disorder (Autism) 08/2020 - 04/2003
3	Lymphocytosis 01/2020 - 06/2010

Drug/Important Bio-Agent (IBA)

220	AntibodiesIBA 01/2022 - 01/2002
101	AutoantibodiesIBA 06/2022 - 03/2002
66	Cholinergic ReceptorsIBA 01/2022 - 01/2002
57	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2002
55	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 05/2021 - 04/2009
45	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 12/2018 - 06/2002
36	muskIBA 01/2022 - 01/2002
35	Immunoglobulin G (IgG)IBA 01/2021 - 09/2003
26	AntigensIBA 01/2021 - 09/2002
25	Phosphotransferases (Kinase)IBA 01/2022 - 01/2002
24	Leucine (L-Leucine)FDA Link 01/2020 - 09/2010
20	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2017 - 03/2005
19	Glycine Receptors (Glycine Receptor)IBA 01/2020 - 08/2011
14	Myelin-Oligodendrocyte GlycoproteinIBA 01/2019 - 09/2012
13	Ion Channels (Ion Channel)IBA 01/2018 - 10/2002
12	Calcium Channels (Calcium Channel)IBA 01/2020 - 06/2002
11	Complement System Proteins (Complement)IBA 01/2018 - 09/2007
10	N-Methylaspartate (NMDA)IBA 01/2022 - 06/2010
9	Potassium Channels (Potassium Channel)IBA 01/2020 - 06/2003
8	Intravenous Immunoglobulins (IVIG)FDA Link 10/2020 - 06/2003
8	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2020 - 10/2005
7	Surface Antigens (Surface Antigen)IBA 01/2021 - 01/2011
7	anti-leucine-rich glioma-inactivated 1 autoantibodyIBA 11/2019 - 05/2011
7	Glutamate Receptors (Glutamate Receptor)IBA 01/2018 - 06/2003
7	SteroidsIBA 05/2017 - 12/2005
7	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2014 - 07/2004
6	Membrane Proteins (Integral Membrane Proteins)IBA 08/2020 - 04/2010
6	Anticonvulsants (Antiepileptic Drugs)IBA 01/2018 - 05/2011
6	Aquaporins (Water Channels)IBA 01/2018 - 02/2010
6	anti-aquaporin 4 autoantibodyIBA 07/2017 - 11/2010
5	Aquaporin 4IBA 01/2018 - 04/2007
5	Oligoclonal BandsIBA 04/2015 - 06/2010
4	Antipsychotic Agents (Antipsychotics)IBA 12/2021 - 01/2013
4	peripheral membrane protein 43KIBA 01/2020 - 06/2002
4	Pharmaceutical PreparationsIBA 01/2020 - 10/2013
4	AcidsIBA 01/2019 - 12/2007
4	Biomarkers (Surrogate Marker)IBA 01/2018 - 02/2014
4	AgrinIBA 01/2016 - 01/2002
4	gamma-Aminobutyric Acid (GABA)IBA 08/2012 - 09/2010
3	Rituximab (Mabthera)FDA Link 12/2021 - 10/2010
3	Polytetrafluoroethylene (Teflon)FDA Link 01/2021 - 01/2018
3	Prednisone (Sone)FDA LinkGeneric 11/2020 - 11/2016
3	RNA (Ribonucleic Acid)IBA 10/2020 - 06/2002
3	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2019 - 03/2009

Therapy/Procedure

49	Immunotherapy 01/2022 - 10/2003
11	Therapeutics 11/2020 - 06/2003
7	Plasma Exchange 12/2021 - 09/2008
4	Thymectomy 12/2020 - 11/2016
4	Immunomodulation 05/2017 - 04/2010